Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
of ccRCC: the role of altered lipid metabolism in resistance to immunotherapy Where to apply Website https://www.unimib.it/lavora-noi/contratti-ricerca/contratti-ricerca-posizioni-… Requirements Additional
-
care services which include but are not limited to allergen immunotherapy prescription order review, medication order review, dispensing and checking of sterile allergen immunotherapy preparations
-
active collaboration with the newly established multidisciplinary California Institute of Immunology and Immunotherapy (CIII), in affiliation with UCLA Health. This is a full-time faculty leadership
-
Dalhousie University | Halifax Mid Harbour Nova Scotia Provincial Government, Nova Scotia | Canada | about 17 hours ago
Chairs program whom they hope to work with. To hire a Impact+ Emerging Leader, Dalhousie must first secure a Canada Impact+ Research Chairs in a complementary research area. Learn more: https
-
approaches to immunotherapies. The focus of the ICCVS is the development of personalized vaccine against non-small cell lung cancer (NSCLC). The approach is based on the use of cancer specific T cells
-
for an experienced oncology nurse to work on our Medical Oncology / Blood Marrow Transplant / Immunotherapy unit. WORK SCHEDULE 90% FTE Variable shifts DEPARTMENT DESCRIPTION 7NE is a 30-bed unit specializing in
-
Job description: Applications are invited for the post of Technician to join Sheffield’s Viral Immunotherapy for Bone Efficacy (VIBE) lab led by Dr Faith Howard based within School of Medicine and
-
The Faculty of Medicine of the University of Zurich invites applications for an Assistant Professorship with Tenure Track in Engineered Immunotherapy, to be filled at the earliest possible date
-
toxicity potential, multiple random assignments, or immunotherapies, etc.) Phase I – IV clinical trials and registries within the ACC CRU Research Team. Complete relevant training to function in the role
-
solid tumors, with a special emphasis on breast cancer. Our discoveries so far include showing how myeloid cell heterogeneity contributes to immunotherapy resistance and revealing how the bone